- Scheme Category:
- Equity Scheme >
- Sectoral/Thematic Funds
NAV: ₹ ↓ -0.25%
NAV chart
SMA (Simple Moving Average)
- 50 SMA
- 100 SMA
- 200 SMA
- 400 SMA
Returns
CAGR returns till date
CAGR returns of Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth and its peers as on 1 October, 2026| Name | YTD | 1D | 1W | 1M | 3M | 1Y | 3Y | 5Y | 7Y | 10Y |
|---|---|---|---|---|---|---|---|---|---|---|
| Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth | 16.77% | -0.25% | -2.96% | -3.01% | 2.78% | 17.5% | 20.1% | 13.97% | 21.72% | - |
| SBI CONSUMPTION OPPORTUNITIES FUND - DIRECT PLAN - GROWTH | -12.49% | -1.3% | -3.53% | -6.07% | -7.61% | -12.86% | 4.04% | 10.56% | 14% | 13.47% |
| SBI ESG Exclusionary Strategy Fund - Direct Plan -Growth | -8.41% | -0.51% | -2.15% | -6.2% | -4.8% | -4.64% | 7.63% | 7.46% | 11.9% | 11.24% |
| SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH | 20.71% | -0.29% | -3.55% | -3.34% | 2.86% | 20.19% | 22.83% | 17.78% | 26.13% | 14.6% |
| SBI INFRASTRUCTURE FUND - DIRECT PLAN - GROWTH | -2.81% | -1% | -2.42% | -3.71% | -6.43% | 0.48% | 11.75% | 15.13% | 18.63% | 15.01% |
| SBI COMMA Fund - DIRECT PLAN - Growth | 2.08% | -1.4% | -3.17% | -5.11% | -1.39% | 7.79% | 14.04% | 9.74% | 18.44% | 14.92% |
Discrete returns (yearly)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Returns | - | - | - | - | 57.54% | 20.14% | -11.24% | 40.42% | 37.69% | -3.36% |
Discrete returns (monthly)
| Month | Dec 2025 | Jan 2026 | Feb 2026 | Mar 2026 | Apr 2026 | May 2026 | Jun 2026 | Jul 2026 | Aug 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Returns | -1.25% | -3.8% | 4.81% | -3.21% | 5.19% | 3.93% | 6.31% | 5.11% | 1.75% | -2.77% |
Returns from spefic dates
| Description | CAGR returns from 18 Oct 2021 (Nifty 50 2021 high) | CAGR returns from 26 Sep 2024 (Nifty 50 2024 high) |
|---|---|---|
| Returns | 14.11% | 6.34% |
Portfolio
Asset allocation
| Equity | Debt | Realestate | Commodities | Cash & Equivalents |
|---|---|---|---|---|
| 96.40% | 0.00% (Arbitrage: 0.00%) | 0.00% | 0.00% | 3.60% |
Equity
| Name | Symbol / ISIN | Sector | Weight % | Other links |
|---|---|---|---|---|
| Torrent Pharmaceuticals Ltd. | TORNTPHARM (INE685A01028) | Pharmaceuticals & Biotechnology | 9.57% | |
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA (INE044A01036) | Pharmaceuticals & Biotechnology | 9.19% | |
| Apollo Hospitals Enterprise Ltd. | APOLLOHOSP (INE437A01024) | Healthcare Services | 6.85% | |
| Cipla Ltd. | CIPLA (INE059A01026) | Pharmaceuticals & Biotechnology | 5.16% | |
| Aurobindo Pharma Ltd. | AUROPHARMA (INE406A01037) | Pharmaceuticals & Biotechnology | 4.53% | |
| Ajanta Pharma Ltd. | AJANTPHARM (INE031B01049) | Pharmaceuticals & Biotechnology | 4.22% | |
| Sai Life Sciences Ltd. | SAILIFE (INE570L01029) | Pharmaceuticals & Biotechnology | 4.20% | |
| Mankind Pharma Ltd. | MANKIND (INE634S01028) | Pharmaceuticals & Biotechnology | 3.41% | |
| Lupin Ltd. | LUPIN (INE326A01037) | Pharmaceuticals & Biotechnology | 3.10% | |
| Abbott India Ltd. | ABBOTINDIA (INE358A01014) | Pharmaceuticals & Biotechnology | 3.03% | |
| Emcure Pharmaceuticals Ltd. | EMCURE (INE168P01015) | Pharmaceuticals & Biotechnology | 2.99% | |
| Fortis Healthcare Ltd. | FORTIS (INE061F01013) | Healthcare Services | 2.79% | |
| IPCA Laboratories Ltd. | IPCALAB (INE571A01038) | Pharmaceuticals & Biotechnology | 2.71% | |
| Gland Pharma Ltd. | GLAND (INE068V01023) | Pharmaceuticals & Biotechnology | 2.63% | |
| Divi's Laboratories Ltd. | DIVISLAB (INE361B01024) | Pharmaceuticals & Biotechnology | 2.23% | |
| Corona Remedies Ltd. | CORONA (INE02ZQ01018) | Pharmaceuticals & Biotechnology | 2.17% | |
| Dr. Lal Path labs Ltd. | LALPATHLAB (INE600L01024) | Healthcare Services | 2.10% | |
| Thyrocare Technologies Ltd. | THYROCARE (INE594H01019) | Healthcare Services | 1.94% | |
| Procter & Gamble Health Ltd. | PGHL (INE199A01012) | Pharmaceuticals & Biotechnology | 1.84% | |
| Jupiter Life Line Hospitals Ltd. | (INE682M01020) | Healthcare Services | 1.76% | |
| Alkem Laboratories Ltd. | ALKEM (INE540L01014) | Pharmaceuticals & Biotechnology | 1.69% | |
| Metropolis Healthcare Ltd. | METROPOLIS (INE112L01020) | Healthcare Services | 1.55% | |
| Shilpa Medicare Ltd. | SHILPAMED (INE790G01031) | Pharmaceuticals & Biotechnology | 1.27% | |
| Piramal Pharma Ltd. | PPLPHARMA (INE0DK501011) | Pharmaceuticals & Biotechnology | 1.24% | |
| Pfizer Ltd. | PFIZER (INE182A01018) | Pharmaceuticals & Biotechnology | 1.19% | |
| Biocon Ltd. | BIOCON (INE376G01013) | Pharmaceuticals & Biotechnology | 1.19% | |
| Sanofi Consumer Healthcare India Ltd. | SANOFICONR (INE0UOS01011) | Pharmaceuticals & Biotechnology | 1.18% | |
| Anthem Biosciences Ltd. | ANTHEM (INE0CZ201020) | Pharmaceuticals & Biotechnology | 1.15% | |
| Manipal Health Enterprises Ltd | (INE459N01021) | Healthcare Services | 1.12% | |
| Vijaya Diagnostic Centre Ltd. | VIJAYA (INE043W01024) | Healthcare Services | 1.08% | |
| Dr. Reddy's Laboratories Ltd. | DRREDDY (INE089A01031) | Pharmaceuticals & Biotechnology | 1.04% | |
| Suraksha Diagnostic Ltd. | SURAKSHA (INE877V01027) | Healthcare Services | 1.03% | |
| Natco Pharma Ltd. | NATCOPHARM (INE987B01026) | Pharmaceuticals & Biotechnology | 0.92% | |
| Glaxosmithkline Pharmaceuticals Ltd. | GLAXO (INE159A01016) | Pharmaceuticals & Biotechnology | 0.90% | |
| Medi Assist Healthcare Services Ltd. | MEDIASSIST (INE456Z01021) | Insurance | 0.78% | |
| Vinati Organics Ltd. | VINATIORGA (INE410B01037) | Chemicals & Petrochemicals | 0.77% | |
| Syngene International Ltd. | SYNGENE (INE398R01022) | Healthcare Services | 0.69% | |
| Max Healthcare Institute Ltd. | MAXHEALTH (INE027H01010) | Healthcare Services | 0.66% | |
| Jubilant Pharmova Ltd. | JUBLPHARMA (INE700A01033) | Pharmaceuticals & Biotechnology | 0.50% |
Portfolio data is as on date 31 August, 2026
NAV history
Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth - 30 days NAV (Net asset value) history
| Date | NAV | % change |
|---|---|---|
| 1 October, 2026 | 39.62 | -0.25% |
| 30 September, 2026 | 39.72 | -1.88% |
| 29 September, 2026 | 40.48 | 0.45% |
| 28 September, 2026 | 40.30 | -1.08% |
| 25 September, 2026 | 40.74 | -0.22% |
| 24 September, 2026 | 40.83 | -0.68% |
| 23 September, 2026 | 41.11 | 0.54% |
| 22 September, 2026 | 40.89 | -0.56% |
| 21 September, 2026 | 41.12 | 0.78% |
| 18 September, 2026 | 40.80 | 1.09% |
| 17 September, 2026 | 40.36 | 1.15% |
| 16 September, 2026 | 39.90 | -0.4% |
| 15 September, 2026 | 40.06 | -1.04% |
| 11 September, 2026 | 40.48 | -0.15% |
| 10 September, 2026 | 40.54 | -0.69% |
| 9 September, 2026 | 40.82 | -0.15% |
| 8 September, 2026 | 40.88 | 0.44% |
| 7 September, 2026 | 40.70 | 0.27% |
| 4 September, 2026 | 40.59 | -0.49% |
| 3 September, 2026 | 40.79 | -0.12% |
| 2 September, 2026 | 40.84 | -0.02% |
| 1 September, 2026 | 40.85 | -0.92% |
| 31 August, 2026 | 41.23 | 0.54% |
| 28 August, 2026 | 41.01 | 0.12% |
| 27 August, 2026 | 40.96 | 0.52% |
| 26 August, 2026 | 40.75 | 0.1% |
| 25 August, 2026 | 40.71 | 0.32% |
| 24 August, 2026 | 40.58 | 0% |
| 21 August, 2026 | 40.58 | -0.29% |
| 20 August, 2026 | 40.70 |
FAQ (Frequently asked questions)
What is latest/current NAV/price of Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth?
The latest NAV of Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth is 39.62 as on 1 October, 2026.What are YTD (year to date) returns of Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth?
The YTD (year to date) returns of Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth are 16.77% as on 1 October, 2026.What are 1 year returns of Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth?
The 1 year returns of Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth are 17.5% as on 1 October, 2026.What are 3 year CAGR returns of Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth?
The 3 year annualized returns (CAGR) of Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth are 20.1% as on 1 October, 2026.What are 5 year CAGR returns of Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth?
The 5 year annualized returns (CAGR) of Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth are 13.97% as on 1 October, 2026.What are top 10 holdings of Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth?
Top 10 holdings of Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth are:- Torrent Pharmaceuticals Ltd.
- Sun Pharmaceutical Industries Ltd.
- Apollo Hospitals Enterprise Ltd.
- Cipla Ltd.
- Aurobindo Pharma Ltd.
- Ajanta Pharma Ltd.
- Sai Life Sciences Ltd.
- Mankind Pharma Ltd.
- Lupin Ltd.
- Abbott India Ltd.
- Emcure Pharmaceuticals Ltd.
What is LTCG (Long term capital gain) and STCG (Short term capital gain) tax for Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth?
Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth is equity oriented mutual fund. Various capital gain taxes are applicable as below (Effective for redemption after July 23, 2024 and from FY 2024-25)Holding period Tax rate Less than 1 year (STCG) 20% More than 1 year (LTCG) Tax free upto Rs. 1.25 lakhs. 12.5% on rest amount.